Reformatting historical data and getting scientists to agree on how to generate it are among the biggest hurdles in hybrid ...
Autolomous CEO Alexander Seyf explains why collaboration, not competition, could unlock progress in cell and gene therapy ...
From scale-up pitfalls to tech transfer nightmares, learn how emerging biotech companies can avoid costly mistakes when ...
Bio-Techne's new Bristol facility strengthens its cell therapy supply chain with GMP small molecule production, complementing ...
Earlier this month, DaltonTx, an AI company specializing in the biotechnology sector, announced the expansion of its ...
Learn strategies for controlling trace metals, polysorbate degradation, and other key formulation risks that can compromise ...
Pharma giant Bayer will invest $2.2B in a New Albany, Ohio manufacturing campus for oncology and cardiovascular drugs, ...
The IND pilot is part of the HHS's ongoing mission to onshore clinical trials.
Helping Downstream Processing To Follow Upstream Innovation. Complex biomolecules place unprecedented demands on conventional ...
Reduced-volume bioburden testing represents a practical and defensible approach for low-volume, high-value cell and gene ...
Sanofi says integrated continuous purification is a “universal solution” for downstream processing as it prepares for clinical production in 2027.
Examine the use of CHT™ XT Media, a ceramic hydroxyapatite mixed-mode resin, to facilitate purification of various large molecule formats.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results